CircABCC3 knockdown inhibits glioblastoma cell malignancy by regulating miR-770-5p/SOX2 axis through PI3K/AKT

Huan Zhang1, Wei Xu2

  • 1Department of Neurosurgery, The Affiliated Chengdu 363 Hospital of Southwest Medical University, Chengdu City, Sichuan Province, China.

Brain Research
|April 3, 2021
PubMed
Abstract

Insights

Circular RNA ABCC3 (circABCC3) promotes glioblastoma by sponging miR-770-5p to upregulate SOX2, activating the PI3K/AKT pathway. This finding offers a basis for circRNA-based glioblastoma therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Circular RNAs (circRNAs) are implicated in glioblastoma (GBM) evolution.
  • The specific role of circ-ATP binding cassette subfamily C member 3 (circABCC3) in GBM remains unclear.

Purpose of the Study:

  • To investigate the effects of circABCC3 on glioblastoma tumorigenesis.
  • To elucidate the underlying molecular mechanisms of circABCC3 in GBM progression.

Main Methods:

  • Quantitative real-time PCR (qRT-PCR) and Western blot analysis were used to measure gene and protein expression.
  • Cellular assays assessed proliferation, migration, invasion, apoptosis, and tube formation.
  • Bioinformatic predictions and experimental assays (dual-luciferase, RIP, pull-down) confirmed molecular interactions.
  • In vivo studies evaluated the impact of circABCC3 knockdown on tumor growth.

Main Results:

  • CircABCC3 and SOX2 were upregulated, while miR-770-5p was downregulated in GBM tissues and cells.
  • CircABCC3 expression correlated with advanced TNM stage in GBM.
  • CircABCC3 knockdown inhibited GBM cell proliferation, migration, invasion, angiogenesis, and PI3K/AKT pathway activation, while promoting apoptosis.
  • CircABCC3 sponged miR-770-5p, which targeted SOX2, and this axis influenced GBM progression.

Conclusions:

  • CircABCC3 drives glioblastoma development through the miR-770-5p/SOX2 axis, modulating the PI3K/AKT pathway.
  • These findings provide a theoretical basis for developing circRNA-targeted therapies for glioblastoma.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.2K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.7K